Union Pacific on Pace for Largest Percent Decrease Since February 2023 — Data Talk
Union Pacific Corporation (UNP) is currently at $236.61, down $7.02 or 2.88%
--Would be lowest close since May 1, 2024, when it closed at $234.96
--On pace for largest percent decrease since Feb. 21, 2023, when it fell 3.89%
--Currently down six of the past seven days
--Currently down four consecutive days; down 4.03% over this period
--Longest losing streak since May 1, 2024, when it fell for four straight trading days
--Worst four day stretch since the four days ending Oct. 26, 2023, when it fell 4.31%
--Down 0.23% month-to-date
--Down 3.67% year-to-date
--Down 14.49% from its all-time closing high of $276.69 on March 30, 2022
--Up 20.49% from 52 weeks ago (May 23, 2023), when it closed at $196.38
--Down 7.9% from its 52-week closing high of $256.91 on Feb. 23, 2024
--Up 23.29% from its 52-week closing low of $191.91 on May 24, 2023
--Traded as low as $235.51; lowest intraday level since May 2, 2024, when it hit $233.20
--Down 3.33% at today's intraday low; largest intraday percent decrease since Feb. 21, 2023, when it fell as much as 3.92%
--10th worst performer in the S&P 500 today
All data as of 9:52:58 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 21, 2024 10:11 ET (14:11 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks